Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of DTaP-Hep B-PRP-T Booster in Filipino Infants
NCT00534833Phase 3Completed
- Sponsor
- Sanofi
- Start
- Sep 2007
- Primary completion
- Sep 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of DTaP-HB-PRP~T vaccine in diphtheria, Tetanus, pertussis, hepatitis B (HBV), Haemophilus influenzae type b disease (Hib), sponsored by Sanofi. Started Sep 2007; status: completed.
02
Drugs
DTaP-HB-PRP~T vaccine
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)Haemophilus influenzae type b disease (Hib)
Beyond the preview
Go deeper on NCT00534833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00534833.